Page last updated: 2024-09-04

butyryl-n-trihexylcitrate and Coronary Restenosis

butyryl-n-trihexylcitrate has been researched along with Coronary Restenosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almalla, M; Burgmaier, M; Reith, S; Schröder, J; Vogt, F	1
Bruno, H; Erglis, A; Graf, K; Hehrlein, C; Hoffman, S; Kornowski, R; Merkely, B; Naber, C; Richardt, G; Slagboom, T; Toelg, R; Witzenbichler, B	1

Other Studies

2 other study(ies) available for butyryl-n-trihexylcitrate and Coronary Restenosis

Article	Year
Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons. Coronary artery disease, 2018, Volume: 29, Issue:8 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2018
Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Butyrates; Coronary Restenosis; Excipients; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries	2014

Article

Year

Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.

Coronary artery disease, 2018, Volume: 29, Issue:8

Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Butyrates; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Equipment Design; Excipients; Female; Humans; Iohexol; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2018

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:5

Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Butyrates; Coronary Restenosis; Excipients; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries

2014